Ismael, Musa M.
HRN: 24-46-58 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2024
CLINDAMYCIN 300MG (CAP)
02/03/2024
02/10/2024
PO
300mg
TID
Cellulitis
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes